| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |